Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Diabetic hyperglycaemia causes a variety of pathological changes in small vessels, arteries and peripheral nerves. Vascular endothelial cells are an important target of hyperglycaemic damage, but the mechanisms underlying this damage are not fully understood. Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoforms; increased formation of glucose-derived advanced glycation end-products; and increased glucose flux through the aldose reductase pathway. The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalities. Hyperglycaemia increases the production of reactive oxygen species inside cultured bovine aortic endothelial cells. Here we show that this increase in reactive oxygen species is prevented by an inhibitor of electron transport chain complex II, by an uncoupler of oxidative phosphorylation, by uncoupling protein-1 and by manganese superoxide dismutase. Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NFkappaB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prolonged elevated glucose could also signal as a cell stressor through multiple pathways, including hyperosmolarity (McGinn et al., 2003), protein kinase C (PKC) activation (Mandarino, 1992), and oxidative damage (Nishikawa et al., 2000), likely involving pS-STAT3, as well as pY-STAT3.”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Nishikawa et al., 2000
In the citing paper
“Certainly ROSs are known to play a substantive role in both insulin resistance [549-556] and in a variety of diabetic sequelae [95,557-559], and mitochondrial dysfunction may be an early step in this [560].”
In the citing paper
“A variety of studies have shown that iron is involved in these signalling processes [1839,1996,2015,2081-2085], probably again acting upstream of the IKK [557,2083,2086,2087].”
In the citing paper
“The preferential use of the liver to dispose a significant amount of the ingested glucose during first pass, along with a 60–70% hepatic clearance of insulin, protect the peripheral circulation from excessive hyperglycemia/hyperinsulinemia in the postprandial period [35,36,37,38,39,40,41,42,43].”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [36]
In the citing paper
“In this way, it was showed that a diet saturated in fats and carbohydrates can cause several mood-related brain mechanisms damage [305].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [305]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01159-9 · Cited by 1,727 · cited 1×
“There appears to be a threshold value above which superoxide production is markedly increase”
BackgroundProtein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330 · cited 1×
“Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoform”
BackgroundDiseases of the mitochondrial DNA
Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319 · cited 1×
“Electron flow through the mitochondrial electron transport chain is carried out by four inner-membrane-associated enzyme complexes, with cytochrome c and the mobile carrier ubiquinon”
BackgroundAdvanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundAmelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103 · cited 1×
“The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalitie”
BackgroundTrumpower, B. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38410-8 · Cited by 595
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13245 · Cited by 564 · cited 1×
“Overexpression of manganese superoxide dismutase (Mn-SOD), the mitochondrial form of this antioxidant enzym”
BackgroundShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Self-citationLee, A. Y., Chung, S. K., & Chung, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2780 · Cited by 310 · cited 1×
“; and increased glucose flux through the aldose reductase pathwa”
Background
Research works printed but not linked: 1
- National Diabetes Data Group Diabetes in America 2nd edn (National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, USA, 1994).
Cited by
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
“However, diabetes alters the primary sites of superoxide generation so that complex II becomes the primary source of electrons that contribute to superoxide formation under diabetic conditions (Nishikawa et al., 2000).”
BackgroundFree Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
“In aorta endothelial cells, a pathologically relevant elevation of the extracellular glucose concentration was shown to cause a massive increase in ROS production by the mitochondrial ETC (415).”
BackgroundInfluentialOxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
“Under certain situations of metabolic stress, even mitochondrial-derived oxidants seem to function as signalling molecule”
BackgroundBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
“This issue has now been resolved by the recent discovery that each of the four different pathogenic mechanisms reflects a single hyperglycaemia-induced process: overproduction of superoxide by the mitochondrial electron-transport chai”
Self-citationIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
“We then determined the cellular pathway involved in increased ROS production in mature adipocytes, including NADPH oxidase, xanthine oxidase (34), and mitochondria-mediated (38) pathways.”
BackgroundOxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Self-citationThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
“We began by asking the following question: What processes are increased by intracellular hyperglycemia in cells whose glucose transport rate is not downregulated by hyperglycemia but not increased in cells whose glucose transport rate is downregulated by hyperglycemia? We discovered that a consistent differentiating f…”
BackgroundSelf-citationTargeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Hyperglycaemia induces an excess of ROS generation by mitochondria, which gives rise to diabetes complications [107] that may persist even when hyperglycemia is controlled.”
BackgroundCheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Superoxide (O2 ) generation by dysfunctional mitochondria in diabetes has been postulated as the primary initiating event in the development of diabetic complications (425).”
BackgroundRole of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
“In each case, activation of these pathways appears to be linked to a hyperglycemia-mediated rise in ROS production and consequent increase in oxidative stress (51, 62).”
BackgroundInfluentialAntioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Role of ROS and RNS Sources in Physiological and Pathological Conditions
Di Meo, S., Reed, T. T., Venditti, P., & Victor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,614
“Taking into account that mitochondrial dysfunction is related to endothelial dysfunction, different studies have demonstrated that blockade of ROS generation can improve endothelial function under hyperglycemia conditions [362, 402].”
BackgroundDiabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Creager, M. A., Lüscher, T. F., of, P. W. T. A., Cosentino, F., & Beckman, J. A. (2003) · Circulation · doi:10.1161/01.cir.0000091257.27563.32 · Cited by 1,650
“Indeed, hyperglycemia-induced ROS production triggers several cellularmechanisms includingpolyol andhexosamine flux, advancedglycation end products (AGEs), protein kinase C (PKC) activation, and NF-kB-mediated vascular inflammation.(12,13) One of the main sources of ROS in the setting of hyperglycemia is represented b…”
BackgroundInfluentialKim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis
Sinha, K., Das, J., Pal, P. B., & Sil, P. C. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1034-4 · Cited by 1,625
“However, complex III is also considered as a significant site of O 2 Á -production (Nishikawa et al. 2000) besides complex I (Turrens and Boveris 1980).”
BackgroundOxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482
“A recent study in bovine endothelial cells found that exposure to hyperglycemia initially increased the production of intracellular ROS, followed by activation of NF- B (22).”
BackgroundDiabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
“lularmechanisms includingpolyol andhexosamine flux, advancedglycation end products (AGEs), protein kinase C (PKC) activation, and NF-kB-mediated vascular inflammation.(12,13) One of the main sources of ROS in the setting of hyperglycemia is represented by PKC and its downstream targets.”
BackgroundInfluentialThe Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
“The cellular sources of reactive oxygen are multiple and include advanced glycation end products, NADH/NADPH oxidases, and the mitochondrial electron transport chain (Nishikawa et al., 2000).”
BackgroundCeriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
“The NADPH oxidases (NOX), a family of seven membrane-bound enzyme complexes, catalyze the reduction of molecular oxygen to O2 ● by using NADPH as electron donor, thus producing ROS as their only function [1-3, 7, 37, 38], and this reflects their specific role in inducing a burst of ROS”
BackgroundInfluentialOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
Sink regulation of photosynthesis
Paul, M. J., & Foyer, C. H. (2001) · Journal of Experimental Botany · doi:10.1093/jexbot/52.360.1383 · Cited by 1,222
Poznyak, A., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051835 · Cited by 1,163
“Naturally, an active search for anti-inflammatory drugs that could reduce the risk of atherosclerotic cardiovascular disease in diabetic patients was conducted during recent years [54].”
BackgroundManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
“Attempts to identify a unifying basic mechanism for many of the diverse effects of acute hyperglycemia point to the ability of hyperglycemia to produce oxidative stress (58,69,120).”
Yu, T., Robotham, J. L., & Yoon, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511154103 · Cited by 1,246
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Self-citationOxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
“pothesis” (11) suggests that the initiator of hyperglycemiainduced damage in the diabetic kidney is excess generation of mitochondrial O2 , which then leads to activation of four major biochemical pathways, including increased AGE formation, activation of protein kinase C isoforms, and increased flux through the polyo…”
BackgroundInfluentialMechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,187
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Self-citationKang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
“All these metabolic abnormities play important roles in the generation of retinal ROS that can in turn augment these metabolic pathways [92], and each pathway interrelates with all the others through ROS or other mid-components.”
BackgroundEl-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Self-citationRole of Mitochondrial Dysfunction in Insulin Resistance
Kim, J.-A., Wei, Y., & Sowers, J. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.165472 · Cited by 1,103
Arsenijevic, D., Onuma, H., Pecqueur, C., Raimbault, S., Manning, B. S., Miroux, B., Couplan, E., Alves-Guerra, M.-C., Goubern, M., Surwit, R., et al. (2000) · Nature Genetics · doi:10.1038/82565 · Cited by 1,079
“Accordingly, it has been postulated that a mild uncoupling of respiration by UCPs could regulate ROS production by modulating proton leakage through the inner mitochondrial membran”
BackgroundSusztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
“Consistent with the hypothesis of Brownlee and colleagues (45,46), high glucose stimulated rapid ROS generation in podocytes from mitochondrial and nonmitochondrial sources.”
BackgroundImmunity, atherosclerosis and cardiovascular disease
Frostegård, J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-117 · Cited by 1,040
“Formation of advanced glycation end products (AGEs) could contribute to atherosclerosis (and CVD) in diabetes since AGEs have proinflammatory and potentially atherogenic properties [27-29].”
BackgroundOxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Geraldes, P., & King, G. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.217117 · Cited by 985
BASTA, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 999
“Indeed, recent studies by Brownlees's group suggest elevated levels of glucose that trigger these processes and indirectly cause increased intracellular generation of superoxide anion and other radicals.(12) This chapter specifically focuses on proposed mechanisms by which AGE accumulate in the extracellular space and…”
BackgroundDiabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
“1) is the trigger that drives each of these pathways (Du et al., 2000; Nishikawa et al., 2000b; Brownlee, 2001). glycation end products, DAG, diacylglycerol; PKC, protein kinase C. Oxidative stress: the common link for hyperglycemic damage Mitochondria are the principal source of ROS in cells as…”
BackgroundInfluentialMolecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
“Indeed, a number of aldose reductase inhibitors are currently being investigated to prevent diabetic complications such as nephropathy, retinopathy, cardiomyopathy, and neuropathy [57,69,70,77], but this point is beyond the scope of this review.”
Backgroundβ-Cell Glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.
Robertson, R. P., Harmon, J., Tran, P. O. T., & Poitout, V. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s119 · Cited by 914
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
“1,2-Diacylglycerol (DAG) induced activation of protein kinase C (PKC); in particular, PKC- has been proposed to play a major role in DN (35).”
BackgroundDu, X. L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., & Brownlee, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11235 · Cited by 907
“Since hyperglycemia activates protein kinase C in BAECs by increasing mitochondrial superoxide production (11), inhibition of this vascular action of insulin in vivo by hyperglycemia could further enhance the difference in eNOS activity between diabetics and nondiabetics.”
BackgroundSelf-citationGlucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897
“Oxidative phosphorylation during anaerobic glycolysis generates reactive oxygen species (ROS), a process that might become excessive in hyperglycemic states (15).”
BackgroundR�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
“Enhanced AGE formation associated with hyperglycemia and oxidative stress inhibits both vascular and metabolic actions of insulin (248).”
BackgroundPisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112891 · Cited by 816
Tan, Y., Zhang, Z., Zheng, C., Wintergerst, K. A., Keller, B. B., & Cai, L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0339-2 · Cited by 835
Li, X., Fang, P., Mai, J., Choi, E. T., Wang, H., & Yang, X.-F. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-19 · Cited by 812
“D1) in the intermembrane space and by SOD2 in the matrix.”
BackgroundMethodInfluentialDiabetic Retinopathy and Diabetic Macular Edema
Ciulla, T. A., Amador, A. G., & Zinman, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2653 · Cited by 836
“Inhibition of superoxide production can effectively block sorbitol accumulation, AGE formation, and PKC activation (125).”
BackgroundDu, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832
“Lastly, incubation of BAECs with 30 mM glucose increased NF-κB activation by twofold, from 188,636 ± 13,333 AU in cells incubated in 5 mM glucose (Figure 2d, bar 1) to 379,053 ± 9,734 AU in cells incubated in 30 mM glucose (Figure 2d, bar 2), as previously described (5).”
BackgroundMethodInfluentialSelf-citationRamasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
“Consistent with this concept, a recent study demonstrated that hyperglycemia-dependent overproduction of mitochondrial superoxide results in NF- B activation (16).”
BackgroundEndothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
“associated production of O2 – , activation of PKC and AGEs formation [147], supporting”
BackgroundBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819
“We propose the following working hypothesis to explain how skeletal muscle oxidative stress could induce mitochondria dysfunctions during HFHSD in mice: chronic elevation of plasma glucose and fatty acid levels leads to energy substrates overflow in muscle, promoting intramyocellular lipids accumulation and inducing R…”
BackgroundResultDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Mitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 797
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
“All of these mechanisms reflect a single hyperglycemia-induced process of overproduction of superoxide by the mitochondrial electron transport chai”
BackgroundSelf-citationSimple non-invasive assessment of advanced glycation endproduct accumulation
Meerwaldt, R., Graaff, R., Oomen, P. H. N., Links, T. P., Jager, J. J., Alderson, N. L., Thorpe, S. R., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1451-2 · Cited by 766
“AGE develop through complex rearrangements of these glycation products [1], and their formation is accelerated by decreased renal clearance of these products [3] and/or oxidative stress [9, 10].”
BackgroundChemical biology of peroxynitrite: Kinetics, diffusion, and radicals
Ferrer-Sueta, G., & Radi, R. (2009) · ACS Chemical Biology · doi:10.1021/cb800279q · Cited by 776
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 769
“Oxidative stress has recently been proposed as the unifying factor for the damaging effect of hyperglycemia (2).”
BackgroundInfluentialVascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
“In accordance with this concept, the normalization of mitochondrial ROS formation prevented hyperglycemic damage by decreasing AGE/RAGE signaling [76].”
BackgroundKolluru, G. K., Bir, S. C., & Kevil, C. G. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/918267 · Cited by 720
“suggest that glucose-induced mitochondrial production of ROS stimulates several biochemical mechanisms involved in diabetic complications, including retinopathy [46].”
BackgroundSivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
“Glycemic effects of this nature have been reported for mitochondria of diverse cell types, including bovine endothelial cells (86, 237), retinal endothelial cells (87), renal mesangial cells (165), cardiomyocytes (338), and epineural blood vessels (70).”
InfluentialSelf-citationRuiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Ceriello, A. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1589 · Cited by 734
“The data in the papers (23) indicate that, at least in the cell culture, endothelium in an environment mimicking physiological hyperglycemia cannot control its appetite for glucose.”
BackgroundInfluentialDelivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Oxidant Mechanisms in Renal Injury and Disease
Ratliff, B. B., Abdulmahdi, W., Pawar, R., & Wolin, M. S. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6665 · Cited by 694
“The excessive availability of glucose enhances glycolysis, which leads to a high mitochondrial proton gradient in PTCs resulting in the elevated production and release of mitochondrial superoxide and ROS (203).”
Fong, D. S., Aiello, L. P., Ferris, F. L., & Klein, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2540 · Cited by 640
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods
Qiu, Y., Liu, Y., Wang, L., Xu, L., Bai, R., Ji, Y., Wu, X., Zhao, Y., Li, Y., & Chen, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.051 · Cited by 689
“The assay of cellular ROS level was performed using CMH2DCFDA as previously reported [39].”
MethodMatough, F. A., Budin, S. B., Hamid, Z. A., Alwahaibi, N., & Mohamed, J. (2012) · Sultan Qaboos University Medical Journal · doi:10.12816/0003082 · Cited by 674
The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions
Li, L., & Yang, X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7580707 · Cited by 634
“Normalizing levels of mitochondrial ROS prevents three pathways of hyperglycaemic damage including glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation, and NFκB activation [36].”
BackgroundUse of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
Thornalley, P. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.013 · Cited by 682
Pericytes and the Pathogenesis of Diabetic Retinopathy
Hammes, H.-P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M., & Deutsch, U. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3107 · Cited by 665
Self-citationVlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Hyperglycemia-Induced Apoptosis in Mouse Myocardium
Cai, L., Li, W., Wang, G., Guo, L., Jiang, Y., & Kang, Y. J. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1938 · Cited by 662
“A direct correlation of hyperglycemia and oxidative stress in diabetic injuries, in particular mitochondrial damage, has been shown (29,36,38,41).”
BackgroundDiabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
“One model upholds the current prevailing theory that in the diabetic kidney, there is increased mtROS, which leads to reduction of AMPK activity and decreased mitochondrial biogenesis (188).”
Matsuda, M., & Shimomura, I. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.05.004 · Cited by 641
“Mitochonrial ROS (described in a previous section) also re involved in the accumulation of AGEs in cells nd activation of the polyol pathway and PKC [56].”
BackgroundMitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Essential Fatty Acids: Biochemistry, Physiology and Pathology
Das, U. N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600012 · Cited by 650
“This is supported by the observation that uncoupling decreases glucose-induced ROS formation, and thus prevents vascular damage in cultured endothelial cells [149].”
BackgroundEndothelial Cell Metabolism in Normal and Diseased Vasculature
Eelen, G., de Zeeuw, P., Simons, M., & Carmeliet, P. (2015) · Circulation Research · doi:10.1161/circresaha.116.302855 · Cited by 627
“Of note, glyceraldehyde-3-phosphate dehydrogenase inactivation and glucose-shunting into glycolytic side branches were remedied by normalizing mitochondrial ROS levels.(57,58) As end products of dysfunctional EC metabolism, AGEs have far reaching effects not only on the ECs’ immediate extracellular surroundings but al…”
BackgroundNADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
“Under these conditions, interstitial fibroblasts transform into myofibroblasts that express (cid”
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
DeFronzo, R. A., Reeves, W. B., & Awad, A. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00393-8 · Cited by 589
Contribution of Polyol Pathway to Diabetes-Induced Oxidative Stress
Chung, S. S. M., Ho, E. C. M., Lam, K. S. L., & Chung, S. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077408.15865.06 · Cited by 609
Yamagishi, S.-I., Edelstein, D., Du, X.-L., Kaneda, Y., Guzmán, M., & Brownlee, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007383200 · Cited by 620
Self-citationMolecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Self-citationDiabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Garcia Soriano, F., Virág, L., Jagtap, P., Szabó, É., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G. K., Salzman, A. L., et al. (2001) · Nature Medicine · doi:10.1038/83241 · Cited by 603
Palmitate-induced Apoptosis Can Occur through a Ceramide-independent Pathway
Listenberger, L. L., Ory, D. S., & Schaffer, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010286200 · Cited by 594
Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
Tabit, C. E., Chung, W. B., Hamburg, N. M., & Vita, J. A. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9134-4 · Cited by 572
“Increased glucose concentrations increase mitochondrial membrane potential and radical production [124, 206].”
BackgroundMitochondrial uncoupling, ROS generation and cardioprotection
Cadenas, S. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.05.019 · Cited by 591
Metadata
- Authors
- Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., Giardino, I., & Brownlee, M.
- Affiliations
- Albert Einstein College of Medicine (US)
- The University of Osaka (JP)
- University of Iowa (US)
- Pfizer (United States) (US)
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Brownlee, Michael
- ORCID
- Venue
- Nature
- Published
- 2000-04
- Volume
- 404
- Issue
- 6779
- Pages
- 787-790
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1529592271
- Cited by
- 4,277
- References
- 23
- Citations by year
- 2026: 83 · 2025: 98 · 2024: 97 · 2023: 107 · 2022: 140 · 2021: 151 · 2020: 169 · 2019: 124 · 2018: 141 · 2017: 164 · 2016: 171 · 2015: 200 · 2014: 220 · 2013: 206 · 2012: 242
- FWCI
- 73.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- mitochondrial superoxide, reactive oxygen species, endothelial cells, protein kinase C, advanced glycation end products, sorbitol accumulation, NF-κB activation, UCP1, manganese superoxide dismutase, mitochondrial uncoupling, diabetic vascular complications
- MeSH terms
- Uncoupling Protein 1, Animals, Aspartic Acid, Blood Glucose, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Carrier Proteins, Cattle, Electron Transport, Endothelium, Vascular, Enzyme Activation, Hyperglycemia, Ion Channels, Malates, Membrane Proteins, Mitochondria, Multienzyme Complexes, Oxidoreductases, Protein Kinase C, Rotenone, Sorbitol, Succinate Dehydrogenase, Superoxide Dismutase, Thenoyltrifluoroacetone, Uncoupling Agents, NF-kappa B, Glycation End Products, Advanced, Reactive Oxygen Species, Mitochondrial Proteins, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.